Cicero Diagnostics, Inc.

Cicero Diagnostics, Inc.

Exclusive Provider of the MyReceptiva test, the first endometriosis detection test with over 90% sensitivity and specificity. Backed by gynecologic surgeons, MyReceptiva testing provides a unique opportunity for womens healthcare providers, determining which patients would benefit most from a referral to an endometriosis surgeon specialist. Cicero Diagnostics currently serves the fertility community by identifying silent endometriosis in patients with failed IVF and/or recurrent pregnancy loss.